Key result
In elderly patients with end-stage renal disease, conservative management resulted in no significant differences in quality of life and symptom burden compared to renal replacement therapy.
Why the study?
Limited studies have evaluated key outcomes of conservative management, such as quality of life, symptoms, and sleep quality, in elderly patients with ESRD.
Does conservative management improve quality of life, symptoms, and sleep quality in elderly patients with end-stage renal disease compared to renal replacement therapy?
Systematic Review (n=1,229)
Does conservative management improve quality of life, symptoms, and sleep quality in elderly patients with end-stage renal disease compared to renal replacement therapy?
Conservative management may be a viable alternative to renal replacement therapy for elderly patients with ESRD, as it provides similar outcomes in terms of quality of life and symptom burden.
Supports conservative management as viable alternative in elderly ESRD; reinforces comparable QoL and symptom outcomes versus dialysis.
BACKGROUND: Older patients with end-stage renal disease (ESRD) have experienced diminished quality of life and debilitating symptoms. Conservative management may be a potential treatment option. Currently, limited studies have been conducted about the main outcome of conservative management, including quality of life, symptoms and sleep quality. The aim of this systematic review was to examine the quality of life, symptoms and sleep quality of elderly patients with ESRD undergoing conservative management. METHODS: Evidence-based medicine database (JBI and Cochrane) and original literature database (PubMed, Medline, EMbase, Web of Science) were searched up to March 12, 2018. The quality of included papers was evaluated with the Newcastle-Ottawa Scale. RESULTS: Eight studies met the inclusion criteria. The total of 1229 patients were involved with an average age of 60.6 ~ 82 years. Patients choosing conservative management were older and more functionally impaired compared to those opting for dialysis. 55% patients undergoing conservative management had stable or improved quality of life and symptoms in prospective cohort study. However, the results revealed that there were no significant differences in quality of life and symptom between conservative management and renal replacement therapy. Only one study assessed quality of life of older patients using SF-36, with a lower score in physical health subscale of conservative management patients than those of renal replacement therapy. Although more than 40% of the patients had poor sleep quality, no significant difference was found between conservative management and renal replacement therapy. Sleep disorders were associated with fatigue and other symptoms. CONCLUSIONS: Although there is a limited literature, conservative management is likely to improve quality of life and alleviate symptoms of end-stage renal disease patients with considerable clinical implications mainly in elderly patients. Future study should pay more attention to the various treatment outcomes of conservative management, providing abundant evidence.
No takes yet. Share an insight, caveat, or question.
Ren et al. (2019) conducted a systematic review in End-stage renal disease (ESRD) (n=1,229). Conservative management vs. Renal replacement therapy (dialysis) or other controls was evaluated on Quality of life, symptoms, and sleep quality. In elderly patients with end-stage renal disease, conservative management resulted in no significant differences in quality of life and symptom burden compared to renal replacement therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: